Makoto Miyazaki
R&D Japan, AstraZeneca K.K
Tokyo, 1080023, Japan
Tokyo, 1080023, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Recommendations for generating real-world evidence with regulatory-grade relevance and reliability.
Journal: International journal of clinical oncology
Published: June 09, 2026
Training Needs Analysis on the Conducting Doctor to Doctor Telemedicine Conference/Consultations in Asian Medical Institutions.
Journal: Studies in health technology and informatics
Published: August 08, 2025
Relationship between the subjective age, higher-life function, and new certification as needing long-term care in community-dwelling older adults: The KAGUYA project longitudinal survey of older adults
Journal: Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
Published: January 03, 2024
Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan.
Journal: Infectious diseases and therapy
Published: November 29, 2023
Prediction of the 4-Year Incidence Risk of Ischemic Stroke in Healthy Japanese Adults: The Fukushima Health Database.
Journal: Journal of atherosclerosis and thrombosis
Published: September 04, 2023
Development of a Japanese Healthy Diet Index: The Fukushima Health Management Survey 2011.
Journal: International journal of environmental research and public health
Published: October 31, 2022
Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors.
Journal: Cancers
Published: June 29, 2022
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease.
Journal: Annals of hepatology
Published: January 06, 2022
Impact of local vaccine subsidization programs on the prevention of mumps in Japan.
Journal: Human vaccines & immunotherapeutics
Published: October 06, 2021
Last Updated: 09/26/2026